47
Participants
Start Date
January 31, 2007
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
sunitinib malate (Sutent)
Sutent administered PO QD from days 1 to 28 Two weeks after completion of any chemotherapy, maintenance Sutent in 6 week cycles (consisting of Sutent 50 mg PO QD weeks 1-4 followed by no treatment weeks 5-6) until progression or death If no chemotherapy is planned, maintenance Sutent (as described above) will start on day 43.
radiotherapy
Radiation is to be delivered to each site over 10 fractions separated by at least 16 hours. Up to 5 sites may be treated
Icahn School of Medicine at Mount Sinai, New York
Collaborators (1)
Pfizer
INDUSTRY
Icahn School of Medicine at Mount Sinai
OTHER